{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:44:59Z","timestamp":1778247899657,"version":"3.51.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research center of IPO Porto","award":["74-CI-IPOP-19-2015"],"award-info":[{"award-number":["74-CI-IPOP-19-2015"]}]},{"name":"Nucleo regional do norte da Liga Portuguesa contra o Cancro","award":["LPCC-NRN 2023"],"award-info":[{"award-number":["LPCC-NRN 2023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"DOI":"10.1186\/s13643-025-02860-w","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T08:34:27Z","timestamp":1748853267000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Circulating cell-free DNA methylation as biomarker for lung cancer detection: a systematic review and meta-analysis of diagnostic studies"],"prefix":"10.1186","volume":"14","author":[{"given":"Diana In\u00eas","family":"Machado","sequence":"first","affiliation":[]},{"given":"Tiago","family":"Brito-Rocha","sequence":"additional","affiliation":[]},{"given":"Sofia","family":"Salta","sequence":"additional","affiliation":[]},{"given":"Teresa","family":"Monjardino","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Henrique","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4186-5345","authenticated-orcid":false,"given":"Carmen","family":"Jer\u00f3nimo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"issue":"3","key":"2860_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"2860_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.mcna.2018.12.006","volume":"103","author":"F Nasim","year":"2019","unstructured":"Nasim F, Sabath BF, Eapen GA. Lung cancer. Med Clin North Am. 2019;103(3):463\u201373. https:\/\/doi.org\/10.1016\/j.mcna.2018.12.006.","journal-title":"Med Clin North Am"},{"key":"2860_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-40389-2_1","volume":"170","author":"GX Wu","year":"2016","unstructured":"Wu GX, Raz DJ. Lung cancer screening. Cancer Treat Res. 2016;170:1\u201323. https:\/\/doi.org\/10.1007\/978-3-319-40389-2_1.","journal-title":"Cancer Treat Res"},{"issue":"6","key":"2860_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/jamasurg.2021.0242","volume":"156","author":"YL Colson","year":"2021","unstructured":"Colson YL, Shepard JO, Lennes IT. New USPSTF guidelines for lung cancer screening: better but not enough. JAMA Surg. 2021;156(6):513\u20134. https:\/\/doi.org\/10.1001\/jamasurg.2021.0242.","journal-title":"JAMA Surg"},{"key":"2860_CR5","doi-asserted-by":"publisher","first-page":"S139","DOI":"10.1016\/j.canep.2015.10.021","volume":"39","author":"P Armaroli","year":"2015","unstructured":"Armaroli P, Villain P, Suonio E, Almonte M, Anttila A, Atkin WS, et al. European Code against Cancer, 4th Edition: Cancer screening. Cancer Epidemiology. 2015;39:S139\u201352. https:\/\/doi.org\/10.1016\/j.canep.2015.10.021.","journal-title":"Cancer Epidemiology."},{"issue":"1","key":"2860_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12943-022-01543-7","volume":"21","author":"SN Lone","year":"2022","unstructured":"Lone SN, Nisar S, Masoodi T, Singh M, Rizwan A, Hashem S, et al. Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments. Mol Cancer. 2022;21(1):79. https:\/\/doi.org\/10.1186\/s12943-022-01543-7.","journal-title":"Mol Cancer"},{"issue":"3","key":"2860_CR7","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3390\/cells9030624","volume":"9","author":"V Const\u00e2ncio","year":"2020","unstructured":"Const\u00e2ncio V, Nunes SP, Henrique R, Jer\u00f3nimo C. DNA methylation-based testing in liquid biopsies as detection and prognostic biomarkers for the four major cancer types. Cells. 2020;9(3):624. https:\/\/doi.org\/10.3390\/cells9030624.","journal-title":"Cells"},{"key":"2860_CR8","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3389\/fgene.2019.00621","volume":"10","author":"J Beltran-Garcia","year":"2019","unstructured":"Beltran-Garcia J, Osca-Verdegal R, Mena-Molla S, Garcia-Gimenez JL. Epigenetic IVD tests for personalized precision medicine in cancer. Front Genet. 2019;10:621. https:\/\/doi.org\/10.3389\/fgene.2019.00621.","journal-title":"Front Genet"},{"issue":"2","key":"2860_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.trecan.2019.12.006","volume":"6","author":"D Roy","year":"2020","unstructured":"Roy D, Tiirikainen M. Diagnostic power of DNA methylation classifiers for early detection of cancer. Trends Cancer. 2020;6(2):78\u201381. https:\/\/doi.org\/10.1016\/j.trecan.2019.12.006.","journal-title":"Trends Cancer"},{"issue":"4","key":"2860_CR10","first-page":"203","volume":"19","author":"AM \u0160imundi\u0107","year":"2009","unstructured":"\u0160imundi\u0107 AM. Measures of diagnostic accuracy: basic definitions. Ejifcc. 2009;19(4):203\u201311.","journal-title":"Ejifcc"},{"issue":"10","key":"2860_CR11","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","volume":"58","author":"JB Reitsma","year":"2005","unstructured":"Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005;58(10):982\u201390. https:\/\/doi.org\/10.1016\/j.jclinepi.2005.02.022.","journal-title":"J Clin Epidemiol"},{"key":"2860_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/03610918.2018.1489553","volume":"49","author":"H Holling","year":"2019","unstructured":"Holling H, B\u00f6hning W, Masoudi E, B\u00f6hning D, Sangnawakij P. Evaluation of a new version of I 2 with emphasis on diagnostic problems. Communications in Statistics - Simulation and Computation. 2019;49:1\u201331. https:\/\/doi.org\/10.1080\/03610918.2018.1489553.","journal-title":"Communications in Statistics - Simulation and Computation"},{"key":"2860_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/0002716202250791","volume":"587","author":"M Lipsey","year":"2003","unstructured":"Lipsey M. Those confounded moderators in meta-analysis: good, bad, and ugly. Annals of The American Academy of Political and Social Science - ANN AMER ACAD POLIT SOC SCI. 2003;587:69\u201381. https:\/\/doi.org\/10.1177\/0002716202250791.","journal-title":"Annals of The American Academy of Political and Social Science - ANN AMER ACAD POLIT SOC SCI"},{"key":"2860_CR14","unstructured":"Organization WH. Cancer today 2020 [Available from: https:\/\/gco.iarc.fr\/today\/online-analysis-multi-bars?v=2020&mode=cancer&mode_population=countries&population=900&populations=900&key=asr&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=10&group_cancer=1&include_nmsc=0&include_nmsc_other=1&type_multiple=%257B%2522inc%2522%253Atrue%252C%2522mort%2522%253Atrue%252C%2522prev%2522%253Afalse%257D&orientation=horizontal&type_sort=0&type_nb_items=%257B%2522top%2522%253Atrue%252C%2522bottom%2522%253Afalse%257D."},{"issue":"3","key":"2860_CR15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","volume":"17","author":"AG Nicholson","year":"2022","unstructured":"Nicholson AG, Tsao MS, Beasley MB, Borczuk AC, Brambilla E, Cooper WA, et al. The 2021 WHO classification of lung tumors: impact of advances since 2015. J Thorac Oncol. 2022;17(3):362\u201387. https:\/\/doi.org\/10.1016\/j.jtho.2021.11.003.","journal-title":"J Thorac Oncol"},{"key":"2860_CR16","unstructured":"Jungner JMGWG. Principles and practices of screening for disease: World Healthy Organization; 1968."},{"key":"2860_CR17","doi-asserted-by":"publisher","first-page":"216365","DOI":"10.1016\/j.canlet.2023.216365","volume":"577","author":"C Li","year":"2023","unstructured":"Li C, Shao J, Li P, Feng J, Li J, Wang C. Circulating tumor DNA as liquid biopsy in lung cancer: Biological characteristics and clinical integration. Cancer Letters. 2023;577:216365. https:\/\/doi.org\/10.1016\/j.canlet.2023.216365.","journal-title":"Cancer Letters."},{"issue":"1","key":"2860_CR18","doi-asserted-by":"publisher","first-page":"16782","DOI":"10.1038\/s41598-021-96242-6","volume":"11","author":"B Wei","year":"2021","unstructured":"Wei B, Wu F, Xing W, Sun H, Yan C, Zhao C, et al. A panel of DNA methylation biomarkers for detection and improving diagnostic efficiency of lung cancer. Scientific Reports. 2021;11(1):16782. https:\/\/doi.org\/10.1038\/s41598-021-96242-6.","journal-title":"Scientific Reports."},{"issue":"1","key":"2860_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13148-020-00828-2","volume":"12","author":"C Chen","year":"2020","unstructured":"Chen C, Huang X, Yin W, Peng M, Wu F, Wu X, et al. Ultrasensitive DNA hypermethylation detection using plasma for early detection of NSCLC: a study in Chinese patients with very small nodules. Clinical Epigenetics. 2020;12(1):39. https:\/\/doi.org\/10.1186\/s13148-020-00828-2.","journal-title":"Clinical Epigenetics."},{"issue":"4","key":"2860_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/15592294.2019.1695333","volume":"15","author":"L Vrba","year":"2020","unstructured":"Vrba L, Oshiro MM, Kim SS, Garland LL, Placencia C, Mahadevan D, et al. DNA methylation biomarkers discovered <i>in silico<\/i> detect cancer in liquid biopsies from non-small cell lung cancer patients. Epigenetics. 2020;15(4):419\u201330. https:\/\/doi.org\/10.1080\/15592294.2019.1695333.","journal-title":"Epigenetics"},{"issue":"1","key":"2860_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13148-022-01334-3","volume":"14","author":"C Palanca-Ballester","year":"2022","unstructured":"Palanca-Ballester C, Hervas D, Villalba M, Valdes-Sanchez T, Garcia D, Alcoriza-Balaguer MI, et al. Translation of a tissue epigenetic signature to circulating free DNA suggests BCAT1 as a potential noninvasive diagnostic biomarker for lung cancer. Clinical Epigenetics. 2022;14(1):116. https:\/\/doi.org\/10.1186\/s13148-022-01334-3.","journal-title":"Clinical Epigenetics."},{"issue":"12","key":"2860_CR22","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1039\/d2bm00044j","volume":"10","author":"\u00c2 Carvalho","year":"2022","unstructured":"Carvalho \u00c2, Guimar\u00e3es-Teixeira C, Const\u00e2ncio V, Fernandes M, Macedo-Silva C, Henrique R, et al. One sample fits all: a microfluidic-assisted methodology for label-free isolation of CTCs with downstream methylation analysis of cfDNA in lung cancer. Biomater Sci. 2022;10(12):3296\u2013308. https:\/\/doi.org\/10.1039\/d2bm00044j.","journal-title":"Biomater Sci"},{"issue":"1","key":"2860_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13148-022-01283-x","volume":"14","author":"\u0391 Markou","year":"2022","unstructured":"Markou \u0391, Londra D, Tserpeli V, Kollias \u0399, Tsaroucha E, Vamvakaris I, et al. DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection. Clinical Epigenetics. 2022;14(1):61. https:\/\/doi.org\/10.1186\/s13148-022-01283-x.","journal-title":"Clinical Epigenetics."},{"issue":"2","key":"2860_CR24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3390\/cancers14020296","volume":"14","author":"Y Kim","year":"2022","unstructured":"Kim Y, Lee BB, Kim D, Um S-W, Han J, Shim YM, et al. Aberrant methylation of SLIT2 gene in plasma cell-free DNA of non-small cell lung cancer patients. Cancers. 2022;14(2):296. https:\/\/doi.org\/10.3390\/cancers14020296.","journal-title":"Cancers"},{"key":"2860_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-022-00604-y","author":"S Zeng","year":"2022","unstructured":"Zeng S, Lin C, Huang Y. miR-375 combined with SHOX2 methylation has higher diagnostic efficacy for non-small-cell lung cancer. Mol Biotechnol. 2022. https:\/\/doi.org\/10.1007\/s12033-022-00604-y.","journal-title":"Mol Biotechnol"},{"issue":"5","key":"2860_CR26","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1007\/s11033-022-07172-z","volume":"49","author":"TTL Vo","year":"2022","unstructured":"Vo TTL, Nguyen TN, Nguyen TT, Pham ATD, Vuong DL, Ta VT, et al. SHOX2 methylation in Vietnamese patients with lung cancer. Mol Biol Rep. 2022;49(5):3413\u201321. https:\/\/doi.org\/10.1007\/s11033-022-07172-z.","journal-title":"Mol Biol Rep"},{"issue":"23","key":"2860_CR27","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.3390\/cancers13236139","volume":"13","author":"M Szczyrek","year":"2021","unstructured":"Szczyrek M, Grenda A, Ku\u017anar-Kami\u0144ska B, Krawczyk P, Sawicki M, Batura-Gabryel H, et al. Methylation of DROSHA and DICER as a biomarker for the detection of lung cancer. Cancers. 2021;13(23):6139. https:\/\/doi.org\/10.3390\/cancers13236139.","journal-title":"Cancers"},{"key":"2860_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.clinbiochem.2021.04.021","volume":"94","author":"MK Park","year":"2021","unstructured":"Park MK, Lee JC, Lee JW, Hwang SJ. Alu cell-free DNA concentration, Alu index, and LINE-1 hypomethylation as a cancer predictor. Clin Biochem. 2021;94:67\u201373. https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.04.021.","journal-title":"Clin Biochem"},{"issue":"1","key":"2860_CR29","doi-asserted-by":"publisher","first-page":"2002682","DOI":"10.1183\/13993003.02682-2020","volume":"57","author":"M Gaga","year":"2021","unstructured":"Gaga M, Chorostowska-Wynimko J, Horv\u00e1th I, Tammemagi MC, Shitrit D, Eisenberg VH, et al. Validation of lung EpiCheck, a novel methylation-based blood assay, for the detection of lung cancer in European and Chinese high-risk individuals. Eur Respir J. 2021;57(1):2002682. https:\/\/doi.org\/10.1183\/13993003.02682-2020.","journal-title":"Eur Respir J"},{"issue":"2","key":"2860_CR30","doi-asserted-by":"publisher","first-page":"898","DOI":"10.7150\/thno.30204","volume":"10","author":"X Li","year":"2020","unstructured":"Li X, Yang T, Li CS, Song Y, Wang D, Jin L, et al. Polymerase chain reaction - surface-enhanced Raman spectroscopy (PCR-SERS) method for gene methylation level detection in plasma. Theranostics. 2020;10(2):898\u2013909. https:\/\/doi.org\/10.7150\/thno.30204.","journal-title":"Theranostics"},{"issue":"12","key":"2860_CR31","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.3390\/cancers12123728","volume":"12","author":"SWC Wen","year":"2020","unstructured":"Wen SWC, Andersen RF, Petersen LMS, Hager H, Hilberg O, Jakobsen A, et al. Comparison of mutated KRAS and methylated HOXA9 tumor-specific DNA in advanced lung adenocarcinoma. Cancers (Basel). 2020;12(12):3728. https:\/\/doi.org\/10.3390\/cancers12123728.","journal-title":"Cancers (Basel)."},{"issue":"5","key":"2860_CR32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2217\/bmm-2019-0325","volume":"14","author":"Z Xu","year":"2020","unstructured":"Xu Z, Wang Y, Wang L, Xiong J, Wang H, Cui F, et al. The performance of the SHOX2\/PTGER4 methylation assay is influenced by cancer stage, age, type and differentiation. Biomark Med. 2020;14(5):341\u201351. https:\/\/doi.org\/10.2217\/bmm-2019-0325.","journal-title":"Biomark Med"},{"issue":"1","key":"2860_CR33","doi-asserted-by":"publisher","first-page":"107327482096970","DOI":"10.1177\/1073274820969703","volume":"27","author":"W Huang","year":"2020","unstructured":"Huang W, Huang H, Zhang S, Wang X, Ouyang J, Lin Z, et al. A novel diagnosis method based on methylation analysis of SHOX2 and serum biomarker for early stage lung cancer. Cancer Control. 2020;27(1):1073274820969703. https:\/\/doi.org\/10.1177\/1073274820969703.","journal-title":"Cancer Control"},{"issue":"16","key":"2860_CR34","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1158\/1078-0432.Ccr-19-2896","volume":"26","author":"B Liu","year":"2020","unstructured":"Liu B, Ricarte Filho J, Mallisetty A, Villani C, Kottorou A, Rodgers K, et al. Detection of promoter DNA methylation in urine and plasma aids the detection of non-small cell lung cancer. Clin Cancer Res. 2020;26(16):4339\u201348. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-19-2896.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2860_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13148-019-0779-x","volume":"11","author":"V Const\u00e2ncio","year":"2019","unstructured":"Const\u00e2ncio V, Nunes SP, Moreira-Barbosa C, Freitas R, Oliveira J, Pousa I, et al. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel. Clinical epigenetics. 2019;11(1):175. https:\/\/doi.org\/10.1186\/s13148-019-0779-x.","journal-title":"Clinical epigenetics."},{"key":"2860_CR36","doi-asserted-by":"publisher","unstructured":"Nunes SP, Diniz F, Moreira-Barbosa C, Const\u00e2ncio V, Silva AV, Oliveira J, et al. Subtyping Lung Cancer Using DNA Methylation in Liquid Biopsies. J Clin Med. 2019;8(9):1500. https:\/\/doi.org\/10.3390\/jcm8091500.","DOI":"10.3390\/jcm8091500"},{"issue":"12","key":"2860_CR37","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.3390\/jcm8122134","volume":"8","author":"M Villalba","year":"2019","unstructured":"Villalba M, Exposito F, Pajares MJ, Sainz C, Redrado M, Remirez A, et al. TMPRSS4: a novel tumor prognostic indicator for the stratification of stage IA tumors and a liquid biopsy biomarker for NSCLC patients. J Clin Med. 2019;8(12):2134. https:\/\/doi.org\/10.3390\/jcm8122134.","journal-title":"J Clin Med"},{"issue":"1","key":"2860_CR38","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/s12967-019-2117-7","volume":"17","author":"R Zang","year":"2019","unstructured":"Zang R, Wang X, Jin R, Lei Y, Huang J, Liu C, et al. Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity. Journal of Translational Medicine. 2019;17(1):430. https:\/\/doi.org\/10.1186\/s12967-019-2117-7.","journal-title":"Journal of Translational Medicine."},{"key":"2860_CR39","doi-asserted-by":"publisher","unstructured":"Nunes S, Moreira-Barbosa C, Salta S, Palma De Sousa S, Pousa I, Oliveira J, et al. Cell-free DNA methylation of selected genes allows for early detection of the major cancers in women. Cancers. 2018;10(10):357. https:\/\/doi.org\/10.3390\/cancers10100357","DOI":"10.3390\/cancers10100357"},{"key":"2860_CR40","doi-asserted-by":"publisher","unstructured":"Yang Z, Qi W, Sun L, Zhou H, Zhou B, Hu Y. DNA methylation analysis of selected genes for the detection of early-stage lung cancer using circulating cell-free DNA. Adv Clin Exp Med. 2019;28(3):355\u201360. https:\/\/doi.org\/10.17219\/acem\/84935","DOI":"10.17219\/acem\/84935"},{"key":"2860_CR41","doi-asserted-by":"publisher","unstructured":"Ooki A, Dinalankara W, Marchionni L, Tsay J-CJ, Goparaju C, Maleki Z, et al. Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma. Oncogene. 2018;37(45):5967\u201381. https:\/\/doi.org\/10.1038\/s41388-018-0373-2","DOI":"10.1038\/s41388-018-0373-2"},{"issue":"9","key":"2860_CR42","doi-asserted-by":"publisher","first-page":"S341","DOI":"10.4103\/0973-1482.235352","volume":"14","author":"X Feng","year":"2018","unstructured":"Feng X, Xie X, Zheng B, Peng C, Zhou H, Qin J. The more potential performance of nidogen 2 methylation by tissue or plasma DNA over brichoalveolar lavage DNA in diagnosis of nonsmall cell lung cancer. J Cancer Res Ther. 2018;14(9):S341\u20136. https:\/\/doi.org\/10.4103\/0973-1482.235352.","journal-title":"J Cancer Res Ther"},{"issue":"6","key":"2860_CR43","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1177\/1533034616682155","volume":"16","author":"MS Aslam","year":"2017","unstructured":"Aslam MS, Shaeer A, Abbas Z, Ahmed A, Gull I, Athar MA. Cell-Free DNA quantification and methylation status of DCC gene as predictive diagnostic biomarkers of lung cancer in patients reported at Gulab Devi Chest Hospital, Lahore. Technol Cancer Res Treat. 2017;16(6):758\u201365. https:\/\/doi.org\/10.1177\/1533034616682155.","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"2860_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jtho.2016.08.123","volume":"12","author":"G Weiss","year":"2017","unstructured":"Weiss G, Schlegel A, Kottwitz D, K\u00f6nig T, Tetzner R. Validation of the SHOX2\/PTGER4 DNA methylation marker panel for plasma-based discrimination between patients with malignant and nonmalignant lung disease. J Thorac Oncol. 2017;12(1):77\u201384. https:\/\/doi.org\/10.1016\/j.jtho.2016.08.123.","journal-title":"J Thorac Oncol"},{"issue":"22","key":"2860_CR45","doi-asserted-by":"publisher","first-page":"7141","DOI":"10.1158\/1078-0432.CCR-17-1222","volume":"23","author":"A Ooki","year":"2017","unstructured":"Ooki A, Maleki Z, Tsay JCJ, Goparaju C, Brait M, Turaga N, et al. A panel of novel detection and prognostic methylated DNA markers in primary non\u2013small cell lung cancer and serum DNA. Clin Cancer Res. 2017;23(22):7141\u201352. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-1222.","journal-title":"Clin Cancer Res"},{"key":"2860_CR46","doi-asserted-by":"publisher","unstructured":"Hulbert A, Jusue-Torres I, Stark A, Chen C, Rodgers K, Lee B, et al., editors. Early detection of lung cancer using DNA promoter hypermethylation in plasma and sputum. Clinical Cancer Research; 2017. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-1371.","DOI":"10.1158\/1078-0432.CCR-16-1371"},{"issue":"4","key":"2860_CR47","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s12094-015-1382-z","volume":"18","author":"T Powr\u00f3zek","year":"2016","unstructured":"Powr\u00f3zek T, Krawczyk P, Nico\u015b M, Ku\u017anar-Kami\u0144ska B, Batura-Gabryel H, Milanowski J. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients. Clin Transl Oncol. 2016;18(4):398\u2013404. https:\/\/doi.org\/10.1007\/s12094-015-1382-z.","journal-title":"Clin Transl Oncol"},{"issue":"6","key":"2860_CR48","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/01902148.2016.1214191","volume":"42","author":"T Powr\u00f3zek","year":"2016","unstructured":"Powr\u00f3zek T, Krawczyk P, Ku\u017anar-Kami\u0144ska B, Batura-Gabryel H, Milanowski J. Analysis of RTEL1 and PCDHGB6 promoter methylation in circulating-free DNA of lung cancer patients using liquid biopsy: a pilot study. Exp Lung Res. 2016;42(6):307\u201313. https:\/\/doi.org\/10.1080\/01902148.2016.1214191.","journal-title":"Exp Lung Res"},{"issue":"2","key":"2860_CR49","doi-asserted-by":"publisher","first-page":"246","DOI":"10.4149\/210_150419N208","volume":"63","author":"M Konecny","year":"2016","unstructured":"Konecny M, Markus J, Waczulikova I, Dolesova L, Kozlova R, Repiska V, et al. The value of SHOX2 methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and other lung disorders. Neoplasma. 2016;63(2):246\u201353. https:\/\/doi.org\/10.4149\/210_150419N208.","journal-title":"Neoplasma"},{"key":"2860_CR50","doi-asserted-by":"publisher","unstructured":"Balgkouranidou I, Chimonidou M, Milaki G, Tsaroucha E, Kakolyris S, Georgoulias V, et al. SOX17 promoter methylation in plasma circulating tumor DNA of patients with non-small cell lung cancer. Clinical Chemistry and Laboratory Medicine. 2016;54(8):1385\u201393. https:\/\/doi.org\/10.1515\/cclm-2015-0776","DOI":"10.1515\/cclm-2015-0776"},{"issue":"3","key":"2860_CR51","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3978\/j.issn.2072-1439.2015.01.24","volume":"7","author":"L Gao","year":"2015","unstructured":"Gao L, Xie E, Yu T, Chen D, Zhang L, Zhang B, et al. Methylated APC and RASSF1A in multiple specimens contribute to the differential diagnosis of patients with undetermined solitary pulmonary nodules. J Thorac Dis. 2015;7(3):422\u201332. https:\/\/doi.org\/10.3978\/j.issn.2072-1439.2015.01.24.","journal-title":"J Thorac Dis"},{"issue":"8","key":"2860_CR52","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1038\/bjc.2014.104","volume":"110","author":"I Balgkouranidou","year":"2014","unstructured":"Balgkouranidou I, Chimonidou M, Milaki G, Tsarouxa EG, Kakolyris S, Welch DR, et al. Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer. Br J Cancer. 2014;110(8):2054\u201362. https:\/\/doi.org\/10.1038\/bjc.2014.104.","journal-title":"Br J Cancer"},{"key":"2860_CR53","doi-asserted-by":"publisher","unstructured":"Powr\u00f3zek T, Krawczyk P, Kucharczyk T, Milanowski J. Septin 9 promoter region methylation in free circulating DNA\u2014potential role in noninvasive diagnosis of lung cancer: preliminary report. Medical Oncology. 2014;31(4). https:\/\/doi.org\/10.1007\/s12032-014-0917-4","DOI":"10.1007\/s12032-014-0917-4"},{"issue":"1","key":"2860_CR54","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.lungcan.2013.09.008","volume":"83","author":"P Xiao","year":"2014","unstructured":"Xiao P, Chen J-R, Zhou F, Lu C-X, Yang Q, Tao G-H, et al. Methylation of P16 in exhaled breath condensate for diagnosis of non-small cell lung cancer. Lung Cancer. 2014;83(1):56\u201360. https:\/\/doi.org\/10.1016\/j.lungcan.2013.09.008.","journal-title":"Lung Cancer"},{"issue":"13","key":"2860_CR55","doi-asserted-by":"publisher","first-page":"4494","DOI":"10.1158\/1078-0432.CCR-10-3436","volume":"17","author":"S Begum","year":"2011","unstructured":"Begum S, Brait M, Dasgupta S, Ostrow KL, Zahurak M, Carvalho AL, et al. An epigenetic marker panel for detection of lung cancer using cell-free serum DNA. Clin Cancer Res. 2011;17(13):4494\u2013503. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-3436.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"2860_CR56","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1097\/jto.0b013e318226b46f","volume":"6","author":"C Vinayanuwattikun","year":"2011","unstructured":"Vinayanuwattikun C, Sriuranpong V, Tanasanvimon S, Chantranuwat P, Mutirangura A. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer. J Thorac Oncol. 2011;6(11):1818\u201325. https:\/\/doi.org\/10.1097\/jto.0b013e318226b46f.","journal-title":"J Thorac Oncol"},{"issue":"6","key":"2860_CR57","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/CEJ.0b013e3283498eb4","volume":"20","author":"AA Ponomaryova","year":"2011","unstructured":"Ponomaryova AA, Rykova EY, Cherdyntseva NV, Skvortsova TE, Dobrodeev AY, Zav\u2019Yalov AA, et al. RAR\u03b22 gene methylation level in the circulating DNA from blood of patients with lung cancer. Eur J Cancer Prev. 2011;20(6):453\u20135. https:\/\/doi.org\/10.1097\/CEJ.0b013e3283498eb4.","journal-title":"Eur J Cancer Prev"},{"issue":"10","key":"2860_CR58","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1097\/jto.0b013e318220ef9a","volume":"6","author":"C Kneip","year":"2011","unstructured":"Kneip C, Schmidt B, Seegebarth A, Weickmann S, Fleischhacker M, Liebenberg V, et al. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma. J Thorac Oncol. 2011;6(10):1632\u20138. https:\/\/doi.org\/10.1097\/jto.0b013e318220ef9a.","journal-title":"J Thorac Oncol"},{"issue":"13","key":"2860_CR59","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1158\/1078-0432.ccr-09-3304","volume":"16","author":"KL Ostrow","year":"2010","unstructured":"Ostrow KL, Hoque MO, Loyo M, Brait M, Greenberg A, Siegfried JM, et al. Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specific PCR. Clin Cancer Res. 2010;16(13):3463\u201372. https:\/\/doi.org\/10.1158\/1078-0432.ccr-09-3304.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2860_CR60","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.lungcan.2006.12.007","volume":"56","author":"Y Wang","year":"2007","unstructured":"Wang Y, Yu Z, Wang T, Zhang J, Hong L, Chen L. Identification of epigenetic aberrant promoter methylation of RASSF1A in serum DNA and its clinicopathological significance in lung cancer. Lung Cancer. 2007;56(2):289\u201394. https:\/\/doi.org\/10.1016\/j.lungcan.2006.12.007.","journal-title":"Lung Cancer"},{"issue":"2","key":"2860_CR61","first-page":"371","volume":"62","author":"H Usadel","year":"2002","unstructured":"Usadel H, Jer\u00f3nimo C, Harden S, Engles J, Sidransky D, Yang S, et al. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Can Res. 2002;62(2):371\u20135.","journal-title":"Can Res"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-025-02860-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-025-02860-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-025-02860-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T08:34:30Z","timestamp":1748853270000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-025-02860-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2860"],"URL":"https:\/\/doi.org\/10.1186\/s13643-025-02860-w","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"5 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"120"}}